United Therapeutics
UTHR
UTHR
662 hedge funds and large institutions have $13.7B invested in United Therapeutics in 2025 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 253 increasing their positions, 223 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
3% less call options, than puts
Call options by funds: $43.4M | Put options by funds: $44.7M
12% less capital invested
Capital invested by funds: $15.5B → $13.7B (-$1.85B)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Holders
662
Holding in Top 10
10
Calls
$43.4M
Puts
$44.7M
Top Buyers
| 1 | +$101M | |
| 2 | +$84.8M | |
| 3 | +$71.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$65.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$52.1M |
Top Sellers
| 1 | -$135M | |
| 2 | -$101M | |
| 3 | -$85.2M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$78.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$64.2M |
